Status:
COMPLETED
Technical Innovation Protocol for MR & US Plaque Imaging: Reproducibility.
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Atherosclerosis
Eligibility:
All Genders
Brief Summary
The aim of this study is to develop non-invasive MRI, and MRS approaches that will quantify the plaque composition and lipid content of plaques and will have the potential for repeated in vivo measure...
Eligibility Criteria
Inclusion
- Patients, with 30 to 70% carotid artery stenosis on ultrasound duplex, who will not go for endarterectomy.
Exclusion
- Metal in the body, as a result of e.g. pacemaker or artificial cardiac valves; claustrophobia; surgery performed in the area of measurement (Carotid artery region); Cardiac arrhythmias.
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01196221
Start Date
November 1 2009
End Date
September 1 2010
Last Update
September 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center
Amsterdam, North Holland, Netherlands, 1105AZ